Novartis AG Total Liabilities 2010-2024 | NVS
Novartis AG total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Novartis AG total liabilities for the quarter ending December 31, 2024 were $58.120B, a 9.26% increase year-over-year.
- Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
- Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
- Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.
Novartis AG Annual Total Liabilities (Millions of US $) |
|
---|---|
2024 | $58,120 |
2023 | $53,195 |
2022 | $58,030 |
2021 | $63,973 |
2020 | $71,112 |
2019 | $62,819 |
2018 | $66,871 |
2017 | $58,852 |
2016 | $55,233 |
2015 | $54,434 |
2014 | $54,543 |
2013 | $51,782 |
2012 | $54,928 |
2011 | $51,556 |
2010 | $53,549 |
2009 | $38,043 |
Novartis AG Quarterly Total Liabilities (Millions of US $) |
|
---|---|
2024-12-31 | $58,120 |
2024-09-30 | $60,083 |
2024-06-30 | $55,603 |
2024-03-31 | $54,578 |
2023-12-31 | $53,195 |
2023-09-30 | $74,452 |
2023-06-30 | $59,048 |
2023-03-31 | $60,099 |
2022-12-31 | $58,030 |
2022-09-30 | $57,566 |
2022-06-30 | $59,904 |
2022-03-31 | $63,514 |
2021-12-31 | $63,973 |
2021-09-30 | $64,272 |
2021-06-30 | $69,887 |
2021-03-31 | $71,163 |
2020-12-31 | $71,112 |
2020-09-30 | $75,124 |
2020-06-30 | $69,878 |
2020-03-31 | $72,120 |
2019-12-31 | $62,819 |
2019-09-30 | $63,373 |
2019-06-30 | $64,790 |
2019-03-31 | $90,639 |
2018-12-31 | $66,871 |
2018-09-30 | $64,975 |
2018-06-30 | $65,157 |
2018-03-31 | $64,313 |
2017-12-31 | $58,852 |
2017-09-30 | $62,602 |
2017-06-30 | $63,771 |
2017-03-31 | $64,340 |
2016-12-31 |